Healthcare provider profile · identity verified

Edward Keith Bentson, M.D.

Internal Medicine · HENDERSONVILLE, NC · NPI 1083718639

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	311	94
Levothyroxine Sodium	Levothyroxine Sodium	228	60
Lisinopril	Lisinopril	196	57
Losartan Potassium	Losartan Potassium	181	53
Rosuvastatin Calcium	Rosuvastatin Calcium	181	46
Amlodipine Besylate	Amlodipine Besylate	163	48
Pantoprazole Sodium	Pantoprazole Sodium	155	49
Hydrochlorothiazide	Hydrochlorothiazide	123	36
Omeprazole	Omeprazole	121	35
Gabapentin	Gabapentin	115	27
Montelukast Sodium	Montelukast Sodium	108	32
Simvastatin	Simvastatin	98	25
Eliquis	Apixaban	89	20
Metoprolol Succinate	Metoprolol Succinate	88	21
Tamsulosin Hcl	Tamsulosin Hcl	82	26
Allopurinol	Allopurinol	81	21
Metformin Hcl	Metformin Hcl	78	22
Ezetimibe	Ezetimibe	75	22
Spironolactone	Spironolactone	74	20
Trazodone Hcl	Trazodone Hcl	69	19
Furosemide	Furosemide	67	14
Fluticasone Propionate	Fluticasone Propionate	58	22
Lorazepam	Lorazepam	57	11
Glimepiride	Glimepiride	56	18
Metformin Hcl Er	Metformin Hcl	51	14
Warfarin Sodium	Warfarin Sodium	50	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	49	13
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Cefdinir	Cefdinir	40	28
Enalapril Maleate	Enalapril Maleate	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	16
Synthroid	Levothyroxine Sodium	36	suppressed
Glipizide	Glipizide	34	suppressed
Finasteride	Finasteride	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Prednisone	Prednisone	29	17
Torsemide	Torsemide	29	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Famotidine	Famotidine	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Amoxicillin	Amoxicillin	21	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Diazepam	Diazepam	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Jardiance	Empagliflozin	13	suppressed
Ozempic	Semaglutide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Tretinoin	Tretinoin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error